Sebelius Kathleen

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
8 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sebelius Kathleen's trades of Humacyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-19
US Humacyte Inc (HUMA)
B Purchase
85,795 +17.4%
46.06
US$2,910,375 		85,795 +17.4% 46.06 US$2,910,375
2025-07-16 2025-07-16
PrS Proposed sale
11,918
216.58
US$3,385,554 		11,918 216.58 US$3,385,554
2025-04-08 2025-04-08
US Humacyte Inc (HUMA)
B Purchase
99,882 +16.3%
191.11
US$2,440,048 		99,882 +16.3% 191.11 US$2,440,048
2024-09-11 2024-09-10
US Humacyte Inc (HUMA)
S Sale
1,548 -3.6%
5.39
US$8,344 		1,548 -3.6% 5.39 US$8,344
2024-09-11 2024-09-10
US Humacyte Inc (HUMA)
S Sale
3,634 -8.3%
5.41
US$19,660 		3,634 -8.3% 5.41 US$19,660
2024-09-10 2024-09-10
US Humacyte Inc (HUMA)
PrS Proposed sale
5,182
5.41
US$28,012 		5,182 5.41 US$28,012
2019-06-14 2019-06-12
B Purchase
4,500 +900.0%
8.96
US$40,320 		4,500 +900.0% 8.96 US$40,320
2019-06-14 2019-06-12
B Purchase
300 +150.0%
8.92
US$2,676 		300 +150.0% 8.92 US$2,676
2019-06-14 2019-06-12
B Purchase
100 +100.0%
8.93
US$893 		100 +100.0% 8.93 US$893
2019-06-14 2019-06-12
B Purchase
100 +inf%
8.95
US$895 		100 +inf% 8.95 US$895